 SALT LAKE CITY, Sept. 16, 2021 PRNewswire -- Co-Diagnostics, Inc. Nasdaq: CODX the Company, a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd CoSara, or the JV, its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization CDSCO in India to manufacture and sell its SarageneTM dengue and chikungunya RT-PCR tests as in vitro diagnostics IVD. 